Neoplasm by Morphology — Trials

Neoplasm by Morphology — Trials · CancerIndex

Clinical trials

Registered studies

52,671 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 351–400 of 1,724 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07185997	Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations	recruiting	Phase 3	480	ArriVent BioPharma, Inc.INDUSTRY	17	Sep 1, 2026	clinicaltrials
NCT07223814	Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)	recruiting	Phase 3	875	Stichting Hemato-Oncologie voor Volwassenen Nederland